Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Parnax Lab

Sector: Healthcare | Industry: Drugs & Pharma
R 18.25 -1.10  | -5.68% -44.10% 3.96 15.52
BSE Price: Oct 22, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 22, 2019 18.25 -1.10 -5.68% 17.65 19.35 3,188 16.10 - 18.65
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 2,933 P/B: 0.43 NSE Code:
52-Week Range: R 16.10 - 55.00 Dividend Yield: 0.00% BSE Code: 506128
TTM EPS: R 4.61 Book Value: R 42.10 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Parnax Lab Ltd. -57.56 -17.79 -15.90 -44.10 -22.84 -14.77 6.50
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 3.11 15.18 9.67
Net Profit 213.01 9.64 5.80
EPS 213.03 9.67 5.82
Book Value 9.90 8.93 11.34
Average
Operating Margin 11.34 11.99 12.69
Net Margin 2.98 2.61 3.08
Return on Networth 9.69 8.50 10.70
Return on Investment 11.59 11.94 12.73
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.62 -10.41 2.62
Operating Profit 53.21 -14.61 53.21
Net Profit 110.43 -89.88 110.43
EPS 110.45 -89.85 110.45
TTM
Revenue -2.21 0.90 -2.21
Operating Profit -2.98 4.15 -2.98
Net Profit -14.17 9.73 -14.17
EPS -14.16 9.90 -14.16
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Parnax Lab Ltd. 15.52 106.38 3.92 3.62 9.69 0.43 3.96
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jul 06, 2015 Baiju M Shah  Buy Market 15,000 38.70 5.81
Jun 30, 2015 Baiju M Shah  Buy Market 6,000 32.50 1.95
Jun 29, 2015 Baiju M Shah  Buy Market 15,000 30.80 4.62
Jun 15, 2015 Prakash M Shah  Buy Market 27,000 25.70 6.94
Jun 15, 2015 Prakash Shah  Buy Market 27,000 25.70 6.94
News & Announcements
Contact Information

Company: Parnax Lab Ltd.

Address: Gala No 114 , Bldg . No . 8, Jogani Industrial Complex, Chunabhatti, Mumbai, Maharashtra - 400022 | Phone: 022 - 30015666 | Fax: 022 - 24057708

Website: www.naxparlab.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
1.97
Piotroski F-Score
7
Modified C-Score
1
5-Years Price to Earnings
3.96
5-Years Price to Book
0.43
Earnings Yield
EBIT / Enterprise value
13.99%
PEG
Price / Earnings to growth ratio
0.79
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59